Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
December 2016
NCT01598298Uploaded 10-16-2018
Access via NCI by Request
PDS UID: nci-data-382
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer
Files: NCT01598298-D3
Data DictionaryNCT01598298-D3-Data-Dictionary.pdf
DATANCT01598298-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT01598298-D2
Data DictionaryNCT01598298-D2-Data-Dictionary.pdf
DATANCT01598298-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT01598298-D1
Data DictionaryNCT01598298-D1-Data-Dictionary.pdf
DATANCT01598298-D1-Dataset.csv
OTHERREADME.pdf